Ascendis Pharma A/S Stock Signals
Latest Data & Signals Issued
| Signal Type | Signal Value | Data | |
|---|---|---|---|
| Score | -4.020 | 2 days ( 0.565 % ) | |
| Last Price | $95.06 | -0.565 % | |
| High/ Low | $94.58 - $97.11 | -4.59% | |
| Chg 7 Days | -7.40 % | $102.66 $95.06 | |
| Chg 30 Days | 1.14 % | $93.99 $95.06 | |
| Chg 12 mos | -8.49 % | $103.88 $95.06 | |
| Trend - 3 mos | 16.95 % | Width: 13.64 % | |
| Trend - 12 mos | -23.71 % | Width: 83.72 % | |
| Pred. range - 3 mos | $109.83 - $124.81 | 15.54 % - 31.29 % | |
| Pred. range - 12 mos | $43.42 - $79.77 | -54.32 % - -16.08 % | |
| Short mv avg 3 mos | Sell | 2023-09-18 - 4 days | |
| Long mv avg 3 mos | Sell | 2023-09-19 - 3 days | |
| Short/Long mv avg 3 mos | Buy | 2023-08-01 - 37 days | |
| Short mv avg 12 mos | Sell | 2023-09-18 - 4 days | |
| Long mv avg 12 mos | Sell | 2023-08-16 - 26 days | |
| Short/Long mv avg 12 mos | Buy | 2023-08-08 - 32 days | |
| Pivot Short | Sell | 2023-09-06 - 12 days | |
| Bollinger | Buy | 2023-09-07 - 11 days | |
| MACD | Sell | No Dates Stored For This Signal |
Signals Effectiveness
Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.
Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.
Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).
Stock Score
Bollinger Bands
MACD
Moving Average (7d)
About Ascendis Pharma A/S
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for pediatric achondroplasia. In addition, the company develops Tra... ASND Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
